Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AE Sphingosine-1-phosphate (S1P) receptor modulators
L04AE04 Ponesimod
D11215 Ponesimod (USAN/INN) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Multiple Sclerosis Agents
Ponesimod
D11215 Ponesimod (USAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Sphingolipid
S1PR1
D11215 Ponesimod (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11215
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11215
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11215